<qa>  What is the association between clinical toxicity andor tumor response or activity and biologicV. To study the association between clinical toxicity andor tumor response or activity and biologic pharmacodynamic results associated with erlotinib hydrochloride and Hedgehog antagonist GDC-0449 in patients with metastatic pancreatic cancer. 